secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0000950170-24-055657
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q1 revenue $28.2M, net loss $(0.78)/share; CTO departs, $3.0M restructuring
--------------------------------------------------------------------------------

- Revenue $28.2M, down 16% YoY; service revenue up 36% to $7.7M, recurring revenue up 24%.
- GAAP net loss $(39.9)M ($(0.78)/share); non-GAAP net loss $(29.3)M ($(0.57)/share).
- Total gross margin improved to 29.2% from 19.2% YoY; product margin 38.4% from 25.1%.
- FY 2024 guidance reaffirmed: revenue $145-153M, non-GAAP gross margin low-30% range.
- CTO Jean-Olivier Racine departs May 17; workforce reduction with $3.0M restructuring charge in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024055657/0000950170-24-055657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017024055657/om-20240508.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-055657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer